Q2 21: strong margins drive big earnings surprise
20/07/21 -"Getinge reported solid Q2 21 numbers. Sales were up 3.6% on an organic basis, driven by 36.5% growth in life science and 1.3% in acute care. As expected, the order book continued to decline (-6.1%) ..."
Pages
53
Language
English
Published on
20/07/21
You may also be interested by these reports :
30/07/21
The pandemic seems to have revealed all the oddities in FMC’s business model, which usually benefits from the continued inflow of new patients. Here ...
30/07/21
Benefiting from the strong market recovery, EssilorLuxottica witnessed an acceleration in sales in Q2 with optical growing faster than the sun ...
30/07/21
Back in March 2018 when Healthineers (Reduce, Germany) was given birth by way of an IPO, there was only muted enthusiasm about yet another Siemens ...
29/07/21
Smith & Nephew reported consensus beating Q2 21 sales growth of 40.3%, thanks to a strong recovery in Orthopaedics (+43.4%) and ‘sports medicine & ...